#TCT2022: Big changes on the horizon for treatment of the “silent killer” that affects nearly half of U.S. adults. Will the U.S. healthcare system be ready?
The findings coming out of #TCT2022 highlight yet again how implantable devices and interventional procedures are taking a center stage in the future of treating widespread diseases typically treated with pharmacological interventions in a primary care setting. One of the fascinating findings released at #TCT2022 last week in Boston was out of the Radiance II trial, […]
